Global Tissue Scaffolds Market 2018-2022

組織スキャフォールドの世界市場2018-2022:天然、合成

◆タイトル:Global Tissue Scaffolds Market 2018-2022
◆商品コード:IRTNTR20852
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年2月6日
◆ページ数:131
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、組織スキャフォールドの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、組織スキャフォールドの世界市場規模及び予測、用途別分析、製品別分析、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は組織スキャフォールドの世界市場が2018-2022年期間中に年平均12.14%成長すると予測しています。当レポート上に記載されている主な企業は、Bioventus、Integra Lifesciences、MiMedx Group、Organogenesis 、RTI Surgical 、Smith & Nephew等です。

・エグゼクティブサマリー
・組織スキャフォールドの世界市場:市場概観
・組織スキャフォールドの世界市場:業界の構造分析
・組織スキャフォールドの世界市場:市場規模及び予測
・組織スキャフォールドの世界市場:製品別分析
・組織スキャフォールドの世界市場:用途別分析
・組織スキャフォールドの世界市場:地域別分析
・組織スキャフォールドの世界市場:アジア市場規模
・組織スキャフォールドの世界市場:アメリカ市場規模
・組織スキャフォールドの世界市場:ヨーロッパ市場規模
・組織スキャフォールドの世界市場:主要国別分析
・組織スキャフォールドの世界市場:成長要因
・組織スキャフォールドの世界市場:課題
・組織スキャフォールドの世界市場:市場動向
・組織スキャフォールドの世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Tissue ScaffoldsTissue scaffolds are cell growth supporting structures composed of natural or synthetic biocompatible materials that provide a favorable environment for cell proliferation and differentiation.

Technavio’s analysts forecast the global tissue scaffolds market to grow at a CAGR of 12.14% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global tissue scaffolds market for 2018-2022. To calculate the market size, the report considers the revenue generated from the tissue scaffolds.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Tissue Scaffolds Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bioventus
• Integra Lifesciences
• MiMedx Group
• Organogenesis
• RTI Surgical
• Smith & Nephew

[Market driver]
• Growing occurrence of chronic and acute wounds
• For a full, detailed list, view our report

[Market challenge]
• Limitations of tissue scaffolds
• For a full, detailed list, view our report

[Market trend]
• Increasing technological advances
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing
• Market size and forecast

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Natural tissue scaffolds
• Synthetic tissue scaffolds
• Market opportunity by product

PART 08: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Musculoskeletal
• Dermatological
• Cardiovascular
• Others

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Tissue scaffolds market in Americas
• Tissue scaffolds market in EMEA
• Tissue scaffolds market in APAC
• Key leading countries
• Market opportunity by region

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 13: MARKET TRENDS
• Growing M&A and strategic collaborations
• Increasing technological advances

PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario

PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bioventus
• Integra Lifesciences
• MiMedx Group
• Organogenesis
• RTI Surgical
• Smith & Nephew
• Other prominent vendors

PART 16: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Parent market
Exhibit 02: Global regenerative medicine market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Global tissue scaffolds market – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global natural tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global natural tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 22: Global synthetic tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global synthetic tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Tissue scaffold market by application – Market share 2017-2022 (%)
Exhibit 26: Customer landscape
Exhibit 27: Global tissue scaffolds market – Market share by region 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Tissue scaffolds market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Tissue scaffolds market in Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top two countries in Americas
Exhibit 32: Tissue scaffolds market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Tissue scaffolds market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top two countries in EMEA
Exhibit 35: Tissue scaffolds market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Tissue scaffolds market in APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top two countries in APAC
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity by geography
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Bioventus: Overview
Exhibit 47: Bioventus: Business segments
Exhibit 48: Bioventus: Organizational developments
Exhibit 49: Bioventus: Geographic focus
Exhibit 50: Bioventus: Segment focus
Exhibit 51: Bioventus: Key offerings
Exhibit 52: Bioventus: Key customers
Exhibit 53: Integra LifeSciences: Overview
Exhibit 54: Integra LifeSciences: Business segments
Exhibit 55: Integra LifeSciences: Organizational developments
Exhibit 56: Integra LifeSciences: Geographic focus
Exhibit 57: Integra LifeSciences: Segment focus
Exhibit 58: Integra LifeSciences: Key offerings
Exhibit 59: Integra LifeSciences: Key customers
Exhibit 60: MiMedx Group: Overview
Exhibit 61: MiMedx Group: Business segments
Exhibit 62: MiMedx Group: Organizational developments
Exhibit 63: MiMedx Group: Geographic focus
Exhibit 64: MidMedx Group: Segment focus
Exhibit 65: MidMedx Group: Key offerings
Exhibit 66: MiMedx Group: Key customers
Exhibit 67: Organogenesis: Overview
Exhibit 68: Organogenesis: Business segments
Exhibit 69: Organogenesis: Organizational developments
Exhibit 70: Organogenesis: Geographic focus
Exhibit 71: Organogenesis: Segment focus
Exhibit 72: Organogenesis: Key offerings
Exhibit 73: Organogenesis: Key customers
Exhibit 74: RTI Surgical: Overview
Exhibit 75: RTI Surgical: Business segments
Exhibit 76: RTI Surgical: Organizational developments
Exhibit 77: RTI Surgical: Geographic focus
Exhibit 78: RTI Surgical: Segment focus
Exhibit 79: RTI Surgical: Key offerings
Exhibit 80: RTI Surgical: Key customers
Exhibit 81: Smith & Nephew: Overview
Exhibit 82: Smith & Nephew: Business segments
Exhibit 83: Smith & Nephew: Organizational developments
Exhibit 84: Smith & Nephew: Geographic focus
Exhibit 85: Smith & Nephew: Segment focus
Exhibit 86: Smith & Nephew: Key offerings
Exhibit 87: Smith & Nephew: Key customers



【掲載企業】

Bioventus, Integra Lifesciences, MiMedx Group, Organogenesis, RTI Surgical, and Smith & Nephew

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[組織スキャフォールドの世界市場2018-2022:天然、合成]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆